(Q44133259)

30 November 2017

title

Low-dose topiramate in adults with treatment-resistant partial-onset seizures (English)

1 reference

30 November 2017

A Guberman

1

1 reference

30 November 2017

W Neto

series ordinal

2

1 reference

30 November 2017

C Gassmann-Mayer

series ordinal

3

1 reference

30 November 2017

EPAJ-119 Study Group

series ordinal

4

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

Acta Neurologica Scandinavica

30 November 2017

published in

1 reference

30 November 2017

volume

106

1 reference

30 November 2017

issue

4

1 reference

30 November 2017

page(s)

183-189

1 reference

Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.02071.X

7 January 2021

Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.02071.X

7 January 2021

Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.02071.X

7 January 2021

Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.02071.X

7 January 2021

Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.02071.X

7 January 2021

Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.02071.X

7 January 2021

A double-blind, placebo-controlled study of topiramate in adult patients with refractory partial epilepsy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.02071.X

7 January 2021

Topiramate in refractory epilepsy: a prospective observational study

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.02071.X

7 January 2021

Topiramate-treated cluster headache

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.02071.X

7 January 2021

Topiramate as a mood stabilizer

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.02071.X

7 January 2021

Topiramate titration and tolerability

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.02071.X

7 January 2021

Topiramate rapidly raises brain GABA in epilepsy patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.02071.X

7 January 2021

Topiramate increases brain GABA, homocarnosine, and pyrrolidinone in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.02071.X

7 January 2021

Effects of valproate and other antiepileptic drugs on brain glutamate, glutamine, and GABA in patients with refractory complex partial seizures

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.02071.X

7 January 2021

Homocarnosine and seizure control in juvenile myoclonic epilepsy and complex partial seizures

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.02071.X

7 January 2021

Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.02071.X

7 January 2021

Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.02071.X

7 January 2021

Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0404.2002.02071.X

7 January 2021

10.1034/J.1600-0404.2002.02071.X

Identifiers

DOI

1 reference

30 November 2017

1 reference